Identification of novel OCT4 genetic variant associated with the risk of chronic hepatitis B in a Korean population

被引:5
作者
Shin, Joong-Gon [1 ,2 ]
Cheong, Hyun Sub [3 ]
Lee, Kwanghyun [1 ]
Ju, Bong-Gun [1 ,2 ]
Lee, Jeong-Hoon [5 ]
Yu, Su Jong [5 ]
Yoon, Jung-Hwan [4 ,5 ]
Cheong, Jae Youn [6 ]
Cho, Sung Won [7 ]
Park, Neung Hwa [8 ]
Namgoong, Suhg [1 ]
Kim, Lyoung Hyo [1 ,3 ]
Kim, Yoon Jun [4 ,5 ]
Shin, Hyoung Doo [1 ,2 ,3 ,4 ]
机构
[1] Sogang Univ, Dept Life Sci, Seoul, South Korea
[2] Sogang Univ, Res Inst Basic Sci, Seoul, South Korea
[3] Sogang Univ, SNP Genet Inc, Dep Genet Epidemiol, Seoul, South Korea
[4] Seoul Natl Univ, Dept Internal Med, Seoul, South Korea
[5] Seoul Natl Univ, Liver Res Inst, Seoul, South Korea
[6] Seoul Natl Univ, Boramae Med Ctr, Dept Internal Med, Seoul, South Korea
[7] Ajou Univ, Sch Med, Dept Gastroenterol, Suwon, South Korea
[8] Ulsan Univ Hosp, Dept Internal Med, Ulsan, South Korea
关键词
chronic hepatitis B; Korean population; OCT4; Single nucleotide polymorphism; GENOME-WIDE ASSOCIATION; CANCER STEM-CELL; HEPATOCELLULAR-CARCINOMA; LIVER-REGENERATION; EXPRESSION; HEPATOCYTE; INDUCTION; MARKER; LOCUS;
D O I
10.1111/liv.13245
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims Hepatitis B viral infection is a serious risk factor for chronic hepatitis B (CHB), cirrhosis and hepatocellular carcinoma. Recently, several genome-wide association studies (GWASs) have been conducted to identify important genetic variant associated with the risk of CHB. In our previous GWAS,TCF19 was identified as one of the susceptibility genes for CHB risk (P=4.2x10(-9) at rs1419881). In order to discover possible additional causal variants around TCF19, we performed an association study by genotyping single nucleotide polymorphisms (SNPs) in OCT4, a nearby gene to TCF19. Methods Nineteen OCT4 genetic variants were selected and genotyped in 3902 subjects (1046 CHB patients and 2856 population controls). Results Logistic regression analysis revealed that OCT4 rs1265163 showed the most significant association signal for the risk of CHB (OR=1.46, P=4.78x10(-12)). Linkage disequilibrium and conditional analysis confirmed rs1265163 in OCT4 as a novel genetic marker for CHB susceptibility. The genetic risk scores (GRSs) were calculated to visualize the combined genetic effects of all known CHB-associated loci, including OCT4 rs1265163, which had been identified in this study. Individuals with higher cumulative GRSs showed significantly increased ORs. The luciferase activity of rs885952, a tagging SNP of rs1265163, showed that OCT4 promoter activity was significantly different between the wild-type and SNP mutant form (P<.05). Conclusions This follow-up study to our previous GWAS identified a possible causal genetic variant associated with the risk of CHB, and findings from this study may prove useful in the understanding of genetic susceptibility to CHB.
引用
收藏
页码:354 / 361
页数:8
相关论文
共 31 条
  • [1] Genetic Variants Associated with Complex Human Diseases Show Wide Variation across Multiple Populations
    Adeyemo, A.
    Rotimi, C.
    [J]. PUBLIC HEALTH GENOMICS, 2010, 13 (02) : 72 - 79
  • [2] The expressions of stem cell markers: Oct4, Nanog, Sox2, nucleostemin, Bmi, Zfx, Tcl1, Tbx3, Dppa4, and Esrrb in bladder, colon, and prostate cancer, and certain cancer cell lines
    Amini, Sabrieh
    Fathi, Fardin
    Mobalegi, Jafar
    Sofimajidpour, Heshmatollah
    Ghadimi, Tayyeb
    [J]. ANATOMY & CELL BIOLOGY, 2014, 47 (01) : 1 - 11
  • [3] OCT-4, an embryonic stem cell marker, is highly expressed in bladder cancer
    Atlasi, Yaser
    Mowla, Seyed J.
    Ziaee, Seyed A. M.
    Bahrami, Ahmad-Reza
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2007, 120 (07) : 1598 - 1602
  • [4] Haploview: analysis and visualization of LD and haplotype maps
    Barrett, JC
    Fry, B
    Maller, J
    Daly, MJ
    [J]. BIOINFORMATICS, 2005, 21 (02) : 263 - 265
  • [5] Bhave V, 2015, FASEB J, V29
  • [6] Genes Inducing iPS Phenotype Play a Role in Hepatocyte Survival and Proliferation InVitro and Liver Regeneration InVivo
    Bhave, Vishakha S.
    Paranjpe, Shirish
    Bowen, William C.
    Donthamsetty, Shashikiran
    Bell, Aaron W.
    Khillan, Jaspal S.
    Michalopoulos, George K.
    [J]. HEPATOLOGY, 2011, 54 (04) : 1360 - 1370
  • [7] Management of Hepatocellular Carcinoma: An Update
    Bruix, Jordi
    Sherman, Morris
    [J]. HEPATOLOGY, 2011, 53 (03) : 1020 - 1022
  • [8] Activation of IL6/IGFIR Confers Poor Prognosis of HBV-Related Hepatocellular Carcinoma through Induction of OCT4/NANOG Expression
    Chang, Te-Sheng
    Wu, Yu-Chih
    Chi, Ching-Chi
    Su, Wei-Chi
    Chang, Pey-Jium
    Lee, Kam-Fai
    Tung, Tao-Hsin
    Wang, Jui
    Liu, Jun-Jen
    Tung, Shui-Yi
    Kuo, Liang-Mou
    Ho, Hong-Nerng
    Ling, Thai-Yen
    Huang, Yen-Hua
    [J]. CLINICAL CANCER RESEARCH, 2015, 21 (01) : 201 - 210
  • [9] Genome-Wide Association Study Identifies Possible Genetic Risk Factors for Colorectal Adenomas
    Edwards, Todd L.
    Shrubsole, Martha J.
    Cai, Qiuyin
    Li, Guoliang
    Dai, Qi
    Rex, Douglas K.
    Ulbright, Thomas M.
    Fu, Zhenming
    Delahanty, Ryan H.
    Murff, Harvey J.
    Smalley, Walter
    Ness, Reid M.
    Zheng, Wei
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2013, 22 (07) : 1219 - 1226
  • [10] The role of hepatocytes and oval cells in liver regeneration and repopulation
    Fausto, N
    Campbell, JS
    [J]. MECHANISMS OF DEVELOPMENT, 2003, 120 (01) : 117 - 130